| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, November 1999, p. 2677-2691, Vol. 77, No. 5
*Department of Molecular and Cell Physiology, Medical School Hannover, D-30623 Hannover, Germany; #Laboratory of Physical Biology, National institutes of Health, Bethesda, Maryland 20892-2755, USA; and §Department of Biochemistry, East Carolina University Medical School, Greenville, North Carolina 27858-4354, USA
A method is described for the exchange of native troponin
of single rabbit psoas muscle fibers for externally applied troponin complexes without detectable impairment of functional properties of the
skinned fibers. This approach is used to exchange native troponin for
rabbit skeletal troponin with a fluorescent label (N-((2-(iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole, IANBD) on Cys133 of the troponin I subunit. IANBD-labeled
troponin I has previously been used in solution studies as an indicator
for the state of activation of reconstituted actin filaments (Trybus
and Taylor, 1980. Proc. Natl. Acad. Sci. USA.
77:7209-7213). In the skinned fibers, the fluorescence of this probe
is unaffected when cross-bridges in their weak binding states attach to
actin filaments but decreases either upon the addition of
Ca2+ or when cross-bridges in their strong binding states
attach to actin. Maximum reduction is observed when Ca2+ is
raised to saturating concentrations. Additional attachment of
cross-bridges in strong binding states gives no further reduction of
fluorescence. Attachment of cross-bridges in strong binding states
alone (low Ca2+ concentration) gives only about half of the
maximum reduction seen with the addition of calcium. This illustrates
that fluorescence of IANBD-labeled troponin I can be used to evaluate
thin filament activation, as previously introduced for solution
studies. In addition, at nonsaturating Ca2+ concentrations
IANBD fluorescence can be used for straightforward classification of
states of the myosin head as weak binding (nonactivating) and strong
binding (activating), irrespective of ionic strength or other
experimental conditions. Furthermore, the approach presented here not
only can be used as a means of exchanging native skeletal troponin and
its subunits for a variety of fluorescently labeled or mutant troponin
subunits, but also allows the exchange of native skeletal troponin for
cardiac troponin.
Biophys J, November 1999, p. 2677-2691, Vol. 77, No. 5
© 1999 by the Biophysical Society 0006-3495/99/11/2677/15 $2.00
This article has been cited by other articles:
![]() |
J. Solzin, B. Iorga, E. Sierakowski, D. P. Gomez Alcazar, D. F. Ruess, T. Kubacki, S. Zittrich, N. Blaudeck, G. Pfitzer, and R. Stehle Kinetic Mechanism of the Ca2+-Dependent Switch-On and Switch-Off of Cardiac Troponin in Myofibrils Biophys. J., December 1, 2007; 93(11): 3917 - 3931. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Narolska, N. Piroddi, A. Belus, N. M. Boontje, B. Scellini, S. Deppermann, R. Zaremba, R. J. Musters, C. dos Remedios, K. Jaquet, et al. Impaired Diastolic Function After Exchange of Endogenous Troponin I With C-Terminal Truncated Troponin I in Human Cardiac Muscle Circ. Res., October 27, 2006; 99(9): 1012 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Telley, E. Stussi, J. Denoth, R. Stehle, G. Pfitzer, and K. W. Ranatunga Reply from I. A. Telley, R. Stehle, K. W. Ranatunga, G. Pfitzer, E. Stussi and J. Denoth J. Physiol., July 15, 2006; 574(2): 629 - 630. [Full Text] [PDF] |
||||
![]() |
M. G. Bell, E. B. Lankford, G. E. Gonye, G. C. R. Ellis-Davies, D. A. Martyn, M. Regnier, and R. J. Barsotti Kinetics of Cardiac Thin-Filament Activation Probed by Fluorescence Polarization of Rhodamine-Labeled Troponin C in Skinned Guinea Pig Trabeculae Biophys. J., January 15, 2006; 90(2): 531 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Kruger, S Zittrich, C Redwood, N Blaudeck, J James, J Robbins, G Pfitzer, and R Stehle Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils J. Physiol., April 15, 2005; 564(2): 347 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Sumandea, W. G. Pyle, T. Kobayashi, P. P. de Tombe, and R. J. Solaro Identification of a Functionally Critical Protein Kinase C Phosphorylation Residue of Cardiac Troponin T J. Biol. Chem., September 12, 2003; 278(37): 35135 - 35144. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kohler, Y. Chen, B. Brenner, A. M. Gordon, T. Kraft, D. A. Martyn, M. Regnier, A. J. Rivera, C.-K. Wang, and P. B. Chase Familial hypertrophic cardiomyopathy mutations in troponin I (K183{Delta}, G203S, K206Q) enhance filament sliding Physiol Genomics, July 7, 2003; 14(2): 117 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Resetar, J. M. Stephens, and J. M. Chalovich Troponin-Tropomyosin: An Allosteric Switch or a Steric Blocker? Biophys. J., August 1, 2002; 83(2): 1039 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sokal, N. Li, C. S. Klug, S. Filipek, W. L. Hubbell, W. Baehr, and K. Palczewski Calcium-sensitive Regions of GCAP1 as Observed by Chemical Modifications, Fluorescence, and EPR Spectroscopies J. Biol. Chem., November 9, 2001; 276(46): 43361 - 43373. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |